BACKGROUND: As the African Programme for Onchocerciasis Control (APOC) matured into its 10th year of ensuring community involvement in mass annual treatment of onchocerciasis with ivermectin, there was recognition of a need to study not only annual coverage of ivermectin in villages but also the compliance of individual villagers with these annual treatments. This was based on the concern that while population coverage goals may be achieved each year, there might be segments of the population who systematically are not complying with the annual regimen, thus creating a reservoir of infection and threatening program gains. METHODS: A multi-site study in five APOC sponsored projects in Nigeria and Cameroon was undertaken to identify the socio-demographic correlates of compliance with ivermectin treatment. A total of 8,480 villagers above 9 years of age selected through a systematic random sampling from 101 communities were surveyed to ascertain their levels of compliance, by adapting APOC's standard household ivermectin survey form. Community leaders, community directed distributors (CDDs) of ivermectin and health workers were interviewed with in-depth interview guides, while focus group discussions were held with community members to help explain how socio-demographic factors might affect compliance. RESULTS: Eight-year compliance ranged from 0 to 8 times with 42.9% taking ivermectin between 6-8 times annually (high compliance). In bivariate analysis high compliance was positively associated with being male, over 24 years of age, having been married, not being Christian, having little or no formal education and being in the ethnic majority. These variables were also confirmed through regression analysis based on total times ivermectin was taken over the period. While these factors explained only 8% of the overall variation in compliance, ethnic status and education appeared to be the strongest factors. Those with higher education may be more mobile and harder to reach while neglect of ethnic minorities has also been documented in other programs. CONCLUSION: These findings can help managers of CDTI programmes to ensure ivermectin reaches all segments of the population equally.
BACKGROUND: As the African Programme for Onchocerciasis Control (APOC) matured into its 10th year of ensuring community involvement in mass annual treatment of onchocerciasis with ivermectin, there was recognition of a need to study not only annual coverage of ivermectin in villages but also the compliance of individual villagers with these annual treatments. This was based on the concern that while population coverage goals may be achieved each year, there might be segments of the population who systematically are not complying with the annual regimen, thus creating a reservoir of infection and threatening program gains. METHODS: A multi-site study in five APOC sponsored projects in Nigeria and Cameroon was undertaken to identify the socio-demographic correlates of compliance with ivermectin treatment. A total of 8,480 villagers above 9 years of age selected through a systematic random sampling from 101 communities were surveyed to ascertain their levels of compliance, by adapting APOC's standard household ivermectin survey form. Community leaders, community directed distributors (CDDs) of ivermectin and health workers were interviewed with in-depth interview guides, while focus group discussions were held with community members to help explain how socio-demographic factors might affect compliance. RESULTS: Eight-year compliance ranged from 0 to 8 times with 42.9% taking ivermectin between 6-8 times annually (high compliance). In bivariate analysis high compliance was positively associated with being male, over 24 years of age, having been married, not being Christian, having little or no formal education and being in the ethnic majority. These variables were also confirmed through regression analysis based on total times ivermectin was taken over the period. While these factors explained only 8% of the overall variation in compliance, ethnic status and education appeared to be the strongest factors. Those with higher education may be more mobile and harder to reach while neglect of ethnic minorities has also been documented in other programs. CONCLUSION: These findings can help managers of CDTI programmes to ensure ivermectin reaches all segments of the population equally.
Authors: M Winnen; A P Plaisier; E S Alley; N J D Nagelkerke; G van Oortmarssen; B A Boatin; J D F Habbema Journal: Bull World Health Organ Date: 2002 Impact factor: 9.408
Authors: Mark J Taylor; Kwablah Awadzi; María-Gloria Basáñez; Nana Biritwum; Daniel Boakye; Boakye Boatin; Moses Bockarie; Thomas S Churcher; Alex Debrah; Geoffrey Edwards; Achim Hoerauf; Sabine Mand; Graham Matthews; Mike Osei-Atweneboana; Roger K Prichard; Samuel Wanji; Ohene Adjei Journal: Parasit Vectors Date: 2009-01-21 Impact factor: 3.876
Authors: Afework Hailemariam Tekle; Elizabeth Elhassan; Sunday Isiyaku; Uche V Amazigo; Simon Bush; Mounkaila Noma; Simon Cousens; Adenike Abiose; Jan H Remme Journal: Parasit Vectors Date: 2012-02-07 Impact factor: 3.876
Authors: Guy-Roger Kamga; Fanny N Dissak-Delon; Hugues C Nana-Djeunga; Benjamin D Biholong; Stephen Mbigha Ghogomu; Jacob Souopgui; Joseph Kamgno; Annie Robert Journal: Parasit Vectors Date: 2018-06-19 Impact factor: 4.047
Authors: Samuel Wanji; Jonas A Kengne-Ouafo; Mathias E Esum; Patrick W N Chounna; Nicholas Tendongfor; Bridget F Adzemye; Joan E E Eyong; Isaac Jato; Fabrice R Datchoua-Poutcheu; Elvis Kah; Peter Enyong; David W Taylor Journal: Parasit Vectors Date: 2015-04-02 Impact factor: 3.876
Authors: Samuel Wanji; Jonas A Kengne-Ouafo; Mathias E Esum; Patrick W N Chounna; Bridget F Adzemye; Joan E E Eyong; Isaac Jato; Fabrice R Datchoua-Poutcheu; Raphael A Abong; Peter Enyong; David W Taylor Journal: Parasit Vectors Date: 2015-12-30 Impact factor: 3.876
Authors: Hugo C Turner; Thomas S Churcher; Martin Walker; Mike Y Osei-Atweneboana; Roger K Prichard; María-Gloria Basáñez Journal: PLoS Negl Trop Dis Date: 2013-04-25